Representative cases that Ms. Yu has led to include
- “Composition of detection agents for epithelial tumor cells and preparation method thereof”, which has been granted in many countries such as the United States, Europe, Japan, South Korea, Mexico, and so on.
Some cases drafted by Ms. Yu:
- "Bispecific or multi-specific Ig JR binding protein"
- "A method for the preparation of MG53 multimer and its use"
- "An MG53 mutant and the preparation methods and applications thereof"
Publications that Ms. Yu has authored include
- Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting gp41 pocket,Xiaowen Yu, Lu Lu, Lifeng Cai, et al. Journal of Virology, 2012, 86(1):589-93
- HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain, Lu Lu, Pei Tong, Xiaowen Yu, et al. Biochimica Et Biophysica Acta, 2012, 1818(12):2950-2957
- ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer. Fei Yu, Lu Lu, Qi Liu, Xiaowen Yu, et al. Biochimica Et Biophysica Acta, 2014, 1838(5):1296-1305